FDA Inspection 985869 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 2473015

The FDA completed an inspection of New York Blood Center Enterprises on Aug 22, 2016 in Rye, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 22, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Rye, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.